CD36 and Insulin resistance: Even current finding has shown the pivotal role of another angiogenic regulator, angiopoietin 2 (ANGPT2), in modulating FAT/CD36 and FATP3 expression through integrin α5β1 signaling and key to insulin resistance [179].